Diagnostic Approach and Management of Isolated Neuropathy

Initial Assessment and Diagnostic Considerations

The American Diabetes Association recommends considering other causes of neuropathy in patients with diabetes, as diabetic neuropathy is a diagnosis of exclusion 1, 3
Patients with atypical clinical features or unclear diagnosis should be considered for referral, according to the American Diabetes Association 1, 3
The European Association for the Study of Diabetes suggests that asymmetric presentation is a key factor in determining the need for referral 2
Significant autonomic involvement is a consideration for referral, as stated by the American Diabetes Association 4
The assessment of intraepidermal nerve fiber density through skin biopsy is essential for suspected small-fiber neuropathy, as recommended by the European Association for the Study of Diabetes 2

The American Diabetes Association recommends treating the underlying cause of neuropathy when identified, as this is the most effective approach 3, 6
First-line medications for painful neuropathy include pregabalin, duloxetine, or gabapentin, according to the American Diabetes Association 3, 6
Treatment for autonomic symptoms is generally focused on alleviating specific symptoms, as stated by the American Diabetes Association 4
Up to 50% of diabetic peripheral neuropathy may be asymptomatic, making screening important in at-risk populations, as recommended by the American Diabetes Association 3, 4